nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Docetaxel—skin cancer	0.613	1	CiPCiCtD
Ixabepilone—TUBB4A—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—skin cancer	0.0334	0.109	CbGbCtD
Ixabepilone—TUBB—Docetaxel—skin cancer	0.0279	0.0913	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—skin cancer	0.0279	0.0913	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—skin cancer	0.0279	0.0913	CbGbCtD
Ixabepilone—CYP3A4—Imiquimod—skin cancer	0.00633	0.0207	CbGbCtD
Ixabepilone—CYP3A4—Temozolomide—skin cancer	0.00633	0.0207	CbGbCtD
Ixabepilone—CYP3A4—Vismodegib—skin cancer	0.00439	0.0144	CbGbCtD
Ixabepilone—CYP3A4—Vemurafenib—skin cancer	0.00347	0.0113	CbGbCtD
Ixabepilone—CYP3A4—Docetaxel—skin cancer	0.00119	0.00389	CbGbCtD
Ixabepilone—TUBB4B—skin epidermis—skin cancer	0.001	0.0568	CbGeAlD
Ixabepilone—TUBB4B—Sorafenib—Vismodegib—skin cancer	0.000953	0.667	CbGdCrCtD
Ixabepilone—TUBB—hair follicle—skin cancer	0.000837	0.0475	CbGeAlD
Ixabepilone—TUBB3—connective tissue—skin cancer	0.000724	0.041	CbGeAlD
Ixabepilone—TUBB4B—hair follicle—skin cancer	0.000714	0.0405	CbGeAlD
Ixabepilone—TUBB8—head—skin cancer	0.000625	0.0354	CbGeAlD
Ixabepilone—TUBB2B—nipple—skin cancer	0.0006	0.034	CbGeAlD
Ixabepilone—TUBB—nipple—skin cancer	0.000568	0.0322	CbGeAlD
Ixabepilone—TUBB2A—nipple—skin cancer	0.000565	0.032	CbGeAlD
Ixabepilone—TUBB6—nipple—skin cancer	0.000557	0.0316	CbGeAlD
Ixabepilone—TUBB3—lymphoid tissue—skin cancer	0.000529	0.03	CbGeAlD
Ixabepilone—TUBB4B—nipple—skin cancer	0.000484	0.0275	CbGeAlD
Ixabepilone—TUBB6—Sorafenib—Vismodegib—skin cancer	0.000475	0.333	CbGdCrCtD
Ixabepilone—TUBB4A—connective tissue—skin cancer	0.00044	0.025	CbGeAlD
Ixabepilone—TUBB3—head—skin cancer	0.000426	0.0242	CbGeAlD
Ixabepilone—TUBB2B—connective tissue—skin cancer	0.000426	0.0241	CbGeAlD
Ixabepilone—TUBB1—head—skin cancer	0.000417	0.0236	CbGeAlD
Ixabepilone—TUBB2A—connective tissue—skin cancer	0.000401	0.0227	CbGeAlD
Ixabepilone—TUBB4A—skin of body—skin cancer	0.000398	0.0226	CbGeAlD
Ixabepilone—TUBB6—epithelium—skin cancer	0.000375	0.0213	CbGeAlD
Ixabepilone—TUBB2A—skin of body—skin cancer	0.000362	0.0205	CbGeAlD
Ixabepilone—TUBB6—skin of body—skin cancer	0.000357	0.0202	CbGeAlD
Ixabepilone—TUBB2B—mammalian vulva—skin cancer	0.00035	0.0199	CbGeAlD
Ixabepilone—TUBB4B—connective tissue—skin cancer	0.000343	0.0195	CbGeAlD
Ixabepilone—TUBB—mammalian vulva—skin cancer	0.000332	0.0188	CbGeAlD
Ixabepilone—TUBB2A—mammalian vulva—skin cancer	0.00033	0.0187	CbGeAlD
Ixabepilone—TUBB6—mammalian vulva—skin cancer	0.000325	0.0185	CbGeAlD
Ixabepilone—TUBB4A—lymphoid tissue—skin cancer	0.000322	0.0183	CbGeAlD
Ixabepilone—TUBB4A—female reproductive system—skin cancer	0.000311	0.0176	CbGeAlD
Ixabepilone—TUBB4B—skin of body—skin cancer	0.00031	0.0176	CbGeAlD
Ixabepilone—TUBB2B—female reproductive system—skin cancer	0.0003	0.017	CbGeAlD
Ixabepilone—TUBB6—lymphoid tissue—skin cancer	0.000289	0.0164	CbGeAlD
Ixabepilone—TUBB4B—mammalian vulva—skin cancer	0.000283	0.016	CbGeAlD
Ixabepilone—TUBB2A—female reproductive system—skin cancer	0.000283	0.016	CbGeAlD
Ixabepilone—TUBB6—female reproductive system—skin cancer	0.000279	0.0158	CbGeAlD
Ixabepilone—TUBB4A—head—skin cancer	0.000259	0.0147	CbGeAlD
Ixabepilone—TUBB4B—lymphoid tissue—skin cancer	0.000251	0.0142	CbGeAlD
Ixabepilone—TUBB2B—head—skin cancer	0.000251	0.0142	CbGeAlD
Ixabepilone—TUBB4B—female reproductive system—skin cancer	0.000242	0.0137	CbGeAlD
Ixabepilone—TUBB2A—head—skin cancer	0.000236	0.0134	CbGeAlD
Ixabepilone—TUBB6—head—skin cancer	0.000233	0.0132	CbGeAlD
Ixabepilone—TUBB4B—head—skin cancer	0.000202	0.0115	CbGeAlD
Ixabepilone—TUBB4A—lymph node—skin cancer	0.000182	0.0103	CbGeAlD
Ixabepilone—TUBB2B—lymph node—skin cancer	0.000176	0.00996	CbGeAlD
Ixabepilone—TUBB—lymph node—skin cancer	0.000166	0.00942	CbGeAlD
Ixabepilone—TUBB2A—lymph node—skin cancer	0.000165	0.00937	CbGeAlD
Ixabepilone—TUBB6—lymph node—skin cancer	0.000163	0.00925	CbGeAlD
Ixabepilone—TUBB4B—lymph node—skin cancer	0.000142	0.00804	CbGeAlD
Ixabepilone—Neuropathy peripheral—Temozolomide—skin cancer	0.000102	0.00165	CcSEcCtD
Ixabepilone—Stomatitis—Temozolomide—skin cancer	0.000102	0.00164	CcSEcCtD
Ixabepilone—Urinary tract infection—Temozolomide—skin cancer	0.000102	0.00163	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000101	0.00163	CcSEcCtD
Ixabepilone—Insomnia—Imiquimod—skin cancer	0.000101	0.00162	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Fluorouracil—skin cancer	0.0001	0.00162	CcSEcCtD
Ixabepilone—Paraesthesia—Imiquimod—skin cancer	9.98e-05	0.00161	CcSEcCtD
Ixabepilone—Chills—Bleomycin—skin cancer	9.97e-05	0.00161	CcSEcCtD
Ixabepilone—CYP3A4—female reproductive system—skin cancer	9.95e-05	0.00564	CbGeAlD
Ixabepilone—Dyspnoea—Imiquimod—skin cancer	9.91e-05	0.0016	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Temozolomide—skin cancer	9.88e-05	0.00159	CcSEcCtD
Ixabepilone—Alopecia—Bleomycin—skin cancer	9.82e-05	0.00158	CcSEcCtD
Ixabepilone—Erythema multiforme—Dactinomycin—skin cancer	9.8e-05	0.00158	CcSEcCtD
Ixabepilone—Pneumonia—Fluorouracil—skin cancer	9.68e-05	0.00156	CcSEcCtD
Ixabepilone—Decreased appetite—Imiquimod—skin cancer	9.66e-05	0.00156	CcSEcCtD
Ixabepilone—Hot flush—Docetaxel—skin cancer	9.64e-05	0.00155	CcSEcCtD
Ixabepilone—Infestation NOS—Fluorouracil—skin cancer	9.62e-05	0.00155	CcSEcCtD
Ixabepilone—Infestation—Fluorouracil—skin cancer	9.62e-05	0.00155	CcSEcCtD
Ixabepilone—Hypersensitivity—Vemurafenib—skin cancer	9.6e-05	0.00155	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Imiquimod—skin cancer	9.6e-05	0.00155	CcSEcCtD
Ixabepilone—Fatigue—Imiquimod—skin cancer	9.58e-05	0.00154	CcSEcCtD
Ixabepilone—Menopausal symptoms—Docetaxel—skin cancer	9.55e-05	0.00154	CcSEcCtD
Ixabepilone—Pain—Imiquimod—skin cancer	9.51e-05	0.00153	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Fluorouracil—skin cancer	9.49e-05	0.00153	CcSEcCtD
Ixabepilone—Myocardial infarction—Fluorouracil—skin cancer	9.43e-05	0.00152	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Fluorouracil—skin cancer	9.43e-05	0.00152	CcSEcCtD
Ixabepilone—Haemoglobin—Temozolomide—skin cancer	9.42e-05	0.00152	CcSEcCtD
Ixabepilone—Stomatitis—Fluorouracil—skin cancer	9.38e-05	0.00151	CcSEcCtD
Ixabepilone—Haemorrhage—Temozolomide—skin cancer	9.38e-05	0.00151	CcSEcCtD
Ixabepilone—Urinary tract infection—Fluorouracil—skin cancer	9.35e-05	0.00151	CcSEcCtD
Ixabepilone—Asthenia—Vemurafenib—skin cancer	9.35e-05	0.00151	CcSEcCtD
Ixabepilone—Hypoaesthesia—Temozolomide—skin cancer	9.33e-05	0.0015	CcSEcCtD
Ixabepilone—Chills—Dactinomycin—skin cancer	9.3e-05	0.0015	CcSEcCtD
Ixabepilone—Urinary tract disorder—Temozolomide—skin cancer	9.26e-05	0.00149	CcSEcCtD
Ixabepilone—Pruritus—Vemurafenib—skin cancer	9.22e-05	0.00149	CcSEcCtD
Ixabepilone—Connective tissue disorder—Temozolomide—skin cancer	9.21e-05	0.00148	CcSEcCtD
Ixabepilone—Lethargy—Docetaxel—skin cancer	9.2e-05	0.00148	CcSEcCtD
Ixabepilone—Urethral disorder—Temozolomide—skin cancer	9.19e-05	0.00148	CcSEcCtD
Ixabepilone—Alopecia—Dactinomycin—skin cancer	9.16e-05	0.00148	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Imiquimod—skin cancer	9.09e-05	0.00146	CcSEcCtD
Ixabepilone—Hyponatraemia—Docetaxel—skin cancer	9.05e-05	0.00146	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Docetaxel—skin cancer	9.01e-05	0.00145	CcSEcCtD
Ixabepilone—Anaemia—Bleomycin—skin cancer	8.94e-05	0.00144	CcSEcCtD
Ixabepilone—Diarrhoea—Vemurafenib—skin cancer	8.92e-05	0.00144	CcSEcCtD
Ixabepilone—Erythema multiforme—Temozolomide—skin cancer	8.87e-05	0.00143	CcSEcCtD
Ixabepilone—Abdominal pain—Imiquimod—skin cancer	8.79e-05	0.00142	CcSEcCtD
Ixabepilone—Body temperature increased—Imiquimod—skin cancer	8.79e-05	0.00142	CcSEcCtD
Ixabepilone—Eye disorder—Temozolomide—skin cancer	8.76e-05	0.00141	CcSEcCtD
Ixabepilone—Cardiac disorder—Temozolomide—skin cancer	8.7e-05	0.0014	CcSEcCtD
Ixabepilone—Haemoglobin—Fluorouracil—skin cancer	8.68e-05	0.0014	CcSEcCtD
Ixabepilone—Leukopenia—Bleomycin—skin cancer	8.66e-05	0.00139	CcSEcCtD
Ixabepilone—Haemorrhage—Fluorouracil—skin cancer	8.64e-05	0.00139	CcSEcCtD
Ixabepilone—Dizziness—Vemurafenib—skin cancer	8.62e-05	0.00139	CcSEcCtD
Ixabepilone—Hypoaesthesia—Fluorouracil—skin cancer	8.6e-05	0.00138	CcSEcCtD
Ixabepilone—Angiopathy—Temozolomide—skin cancer	8.51e-05	0.00137	CcSEcCtD
Ixabepilone—Immune system disorder—Temozolomide—skin cancer	8.47e-05	0.00136	CcSEcCtD
Ixabepilone—Mediastinal disorder—Temozolomide—skin cancer	8.45e-05	0.00136	CcSEcCtD
Ixabepilone—Cough—Bleomycin—skin cancer	8.44e-05	0.00136	CcSEcCtD
Ixabepilone—Chills—Temozolomide—skin cancer	8.41e-05	0.00135	CcSEcCtD
Ixabepilone—Dehydration—Docetaxel—skin cancer	8.38e-05	0.00135	CcSEcCtD
Ixabepilone—Anaemia—Dactinomycin—skin cancer	8.34e-05	0.00134	CcSEcCtD
Ixabepilone—Vomiting—Vemurafenib—skin cancer	8.29e-05	0.00133	CcSEcCtD
Ixabepilone—Alopecia—Temozolomide—skin cancer	8.29e-05	0.00133	CcSEcCtD
Ixabepilone—Myalgia—Bleomycin—skin cancer	8.24e-05	0.00133	CcSEcCtD
Ixabepilone—Chest pain—Bleomycin—skin cancer	8.24e-05	0.00133	CcSEcCtD
Ixabepilone—Rash—Vemurafenib—skin cancer	8.22e-05	0.00132	CcSEcCtD
Ixabepilone—Mental disorder—Temozolomide—skin cancer	8.21e-05	0.00132	CcSEcCtD
Ixabepilone—Dermatitis—Vemurafenib—skin cancer	8.21e-05	0.00132	CcSEcCtD
Ixabepilone—Hypersensitivity—Imiquimod—skin cancer	8.19e-05	0.00132	CcSEcCtD
Ixabepilone—Headache—Vemurafenib—skin cancer	8.17e-05	0.00131	CcSEcCtD
Ixabepilone—Malnutrition—Temozolomide—skin cancer	8.16e-05	0.00131	CcSEcCtD
Ixabepilone—Leukopenia—Dactinomycin—skin cancer	8.08e-05	0.0013	CcSEcCtD
Ixabepilone—Asthenia—Imiquimod—skin cancer	7.98e-05	0.00128	CcSEcCtD
Ixabepilone—Oedema—Bleomycin—skin cancer	7.9e-05	0.00127	CcSEcCtD
Ixabepilone—Pruritus—Imiquimod—skin cancer	7.86e-05	0.00127	CcSEcCtD
Ixabepilone—Infection—Bleomycin—skin cancer	7.85e-05	0.00126	CcSEcCtD
Ixabepilone—Dysphagia—Docetaxel—skin cancer	7.79e-05	0.00125	CcSEcCtD
Ixabepilone—Nausea—Vemurafenib—skin cancer	7.74e-05	0.00125	CcSEcCtD
Ixabepilone—Thrombocytopenia—Bleomycin—skin cancer	7.73e-05	0.00125	CcSEcCtD
Ixabepilone—Myalgia—Dactinomycin—skin cancer	7.68e-05	0.00124	CcSEcCtD
Ixabepilone—Alopecia—Fluorouracil—skin cancer	7.63e-05	0.00123	CcSEcCtD
Ixabepilone—Diarrhoea—Imiquimod—skin cancer	7.61e-05	0.00122	CcSEcCtD
Ixabepilone—Angina pectoris—Docetaxel—skin cancer	7.59e-05	0.00122	CcSEcCtD
Ixabepilone—Anaemia—Temozolomide—skin cancer	7.54e-05	0.00121	CcSEcCtD
Ixabepilone—Anorexia—Bleomycin—skin cancer	7.53e-05	0.00121	CcSEcCtD
Ixabepilone—Pancytopenia—Docetaxel—skin cancer	7.4e-05	0.00119	CcSEcCtD
Ixabepilone—Hypotension—Bleomycin—skin cancer	7.38e-05	0.00119	CcSEcCtD
Ixabepilone—Oedema—Dactinomycin—skin cancer	7.37e-05	0.00119	CcSEcCtD
Ixabepilone—Dizziness—Imiquimod—skin cancer	7.35e-05	0.00118	CcSEcCtD
Ixabepilone—Infection—Dactinomycin—skin cancer	7.32e-05	0.00118	CcSEcCtD
Ixabepilone—Leukopenia—Temozolomide—skin cancer	7.31e-05	0.00118	CcSEcCtD
Ixabepilone—Neutropenia—Docetaxel—skin cancer	7.28e-05	0.00117	CcSEcCtD
Ixabepilone—Thrombocytopenia—Dactinomycin—skin cancer	7.21e-05	0.00116	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Bleomycin—skin cancer	7.2e-05	0.00116	CcSEcCtD
Ixabepilone—Cough—Temozolomide—skin cancer	7.12e-05	0.00115	CcSEcCtD
Ixabepilone—Paraesthesia—Bleomycin—skin cancer	7.09e-05	0.00114	CcSEcCtD
Ixabepilone—Vomiting—Imiquimod—skin cancer	7.07e-05	0.00114	CcSEcCtD
Ixabepilone—Weight decreased—Docetaxel—skin cancer	7.05e-05	0.00113	CcSEcCtD
Ixabepilone—Dyspnoea—Bleomycin—skin cancer	7.04e-05	0.00113	CcSEcCtD
Ixabepilone—Anorexia—Dactinomycin—skin cancer	7.02e-05	0.00113	CcSEcCtD
Ixabepilone—Rash—Imiquimod—skin cancer	7.01e-05	0.00113	CcSEcCtD
Ixabepilone—Dermatitis—Imiquimod—skin cancer	7e-05	0.00113	CcSEcCtD
Ixabepilone—Pneumonia—Docetaxel—skin cancer	6.99e-05	0.00113	CcSEcCtD
Ixabepilone—Headache—Imiquimod—skin cancer	6.96e-05	0.00112	CcSEcCtD
Ixabepilone—Anaemia—Fluorouracil—skin cancer	6.95e-05	0.00112	CcSEcCtD
Ixabepilone—Arthralgia—Temozolomide—skin cancer	6.95e-05	0.00112	CcSEcCtD
Ixabepilone—Myalgia—Temozolomide—skin cancer	6.95e-05	0.00112	CcSEcCtD
Ixabepilone—Infestation—Docetaxel—skin cancer	6.95e-05	0.00112	CcSEcCtD
Ixabepilone—Infestation NOS—Docetaxel—skin cancer	6.95e-05	0.00112	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	6.9e-05	0.00111	CcSEcCtD
Ixabepilone—Decreased appetite—Bleomycin—skin cancer	6.87e-05	0.00111	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Docetaxel—skin cancer	6.85e-05	0.0011	CcSEcCtD
Ixabepilone—Renal failure—Docetaxel—skin cancer	6.83e-05	0.0011	CcSEcCtD
Ixabepilone—Myocardial infarction—Docetaxel—skin cancer	6.81e-05	0.0011	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Docetaxel—skin cancer	6.81e-05	0.0011	CcSEcCtD
Ixabepilone—Stomatitis—Docetaxel—skin cancer	6.77e-05	0.00109	CcSEcCtD
Ixabepilone—Jaundice—Docetaxel—skin cancer	6.77e-05	0.00109	CcSEcCtD
Ixabepilone—Pain—Bleomycin—skin cancer	6.75e-05	0.00109	CcSEcCtD
Ixabepilone—Leukopenia—Fluorouracil—skin cancer	6.73e-05	0.00108	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Dactinomycin—skin cancer	6.71e-05	0.00108	CcSEcCtD
Ixabepilone—Oedema—Temozolomide—skin cancer	6.66e-05	0.00107	CcSEcCtD
Ixabepilone—Infection—Temozolomide—skin cancer	6.62e-05	0.00107	CcSEcCtD
Ixabepilone—Nausea—Imiquimod—skin cancer	6.6e-05	0.00106	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Docetaxel—skin cancer	6.57e-05	0.00106	CcSEcCtD
Ixabepilone—Nervous system disorder—Temozolomide—skin cancer	6.53e-05	0.00105	CcSEcCtD
Ixabepilone—Thrombocytopenia—Temozolomide—skin cancer	6.52e-05	0.00105	CcSEcCtD
Ixabepilone—Skin disorder—Temozolomide—skin cancer	6.47e-05	0.00104	CcSEcCtD
Ixabepilone—Chest pain—Fluorouracil—skin cancer	6.4e-05	0.00103	CcSEcCtD
Ixabepilone—Myalgia—Fluorouracil—skin cancer	6.4e-05	0.00103	CcSEcCtD
Ixabepilone—Decreased appetite—Dactinomycin—skin cancer	6.4e-05	0.00103	CcSEcCtD
Ixabepilone—Fatigue—Dactinomycin—skin cancer	6.35e-05	0.00102	CcSEcCtD
Ixabepilone—Anorexia—Temozolomide—skin cancer	6.35e-05	0.00102	CcSEcCtD
Ixabepilone—Pain—Dactinomycin—skin cancer	6.3e-05	0.00101	CcSEcCtD
Ixabepilone—Haemoglobin—Docetaxel—skin cancer	6.27e-05	0.00101	CcSEcCtD
Ixabepilone—Body temperature increased—Bleomycin—skin cancer	6.24e-05	0.00101	CcSEcCtD
Ixabepilone—Haemorrhage—Docetaxel—skin cancer	6.24e-05	0.001	CcSEcCtD
Ixabepilone—Hypoaesthesia—Docetaxel—skin cancer	6.2e-05	0.000999	CcSEcCtD
Ixabepilone—Urinary tract disorder—Docetaxel—skin cancer	6.16e-05	0.000992	CcSEcCtD
Ixabepilone—Oedema—Fluorouracil—skin cancer	6.14e-05	0.000988	CcSEcCtD
Ixabepilone—Connective tissue disorder—Docetaxel—skin cancer	6.13e-05	0.000987	CcSEcCtD
Ixabepilone—Urethral disorder—Docetaxel—skin cancer	6.11e-05	0.000984	CcSEcCtD
Ixabepilone—Infection—Fluorouracil—skin cancer	6.1e-05	0.000982	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Temozolomide—skin cancer	6.07e-05	0.000977	CcSEcCtD
Ixabepilone—Insomnia—Temozolomide—skin cancer	6.03e-05	0.00097	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Dactinomycin—skin cancer	6.02e-05	0.00097	CcSEcCtD
Ixabepilone—Nervous system disorder—Fluorouracil—skin cancer	6.02e-05	0.000969	CcSEcCtD
Ixabepilone—Thrombocytopenia—Fluorouracil—skin cancer	6.01e-05	0.000968	CcSEcCtD
Ixabepilone—Paraesthesia—Temozolomide—skin cancer	5.98e-05	0.000963	CcSEcCtD
Ixabepilone—Dyspnoea—Temozolomide—skin cancer	5.94e-05	0.000956	CcSEcCtD
Ixabepilone—Erythema multiforme—Docetaxel—skin cancer	5.9e-05	0.000949	CcSEcCtD
Ixabepilone—Anorexia—Fluorouracil—skin cancer	5.85e-05	0.000942	CcSEcCtD
Ixabepilone—Eye disorder—Docetaxel—skin cancer	5.83e-05	0.000938	CcSEcCtD
Ixabepilone—Abdominal pain—Dactinomycin—skin cancer	5.82e-05	0.000938	CcSEcCtD
Ixabepilone—Body temperature increased—Dactinomycin—skin cancer	5.82e-05	0.000938	CcSEcCtD
Ixabepilone—Hypersensitivity—Bleomycin—skin cancer	5.82e-05	0.000937	CcSEcCtD
Ixabepilone—Decreased appetite—Temozolomide—skin cancer	5.79e-05	0.000933	CcSEcCtD
Ixabepilone—Cardiac disorder—Docetaxel—skin cancer	5.79e-05	0.000932	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Temozolomide—skin cancer	5.75e-05	0.000926	CcSEcCtD
Ixabepilone—Fatigue—Temozolomide—skin cancer	5.74e-05	0.000925	CcSEcCtD
Ixabepilone—Hypotension—Fluorouracil—skin cancer	5.74e-05	0.000924	CcSEcCtD
Ixabepilone—Pain—Temozolomide—skin cancer	5.7e-05	0.000917	CcSEcCtD
Ixabepilone—Constipation—Temozolomide—skin cancer	5.7e-05	0.000917	CcSEcCtD
Ixabepilone—Asthenia—Bleomycin—skin cancer	5.67e-05	0.000912	CcSEcCtD
Ixabepilone—Angiopathy—Docetaxel—skin cancer	5.66e-05	0.000911	CcSEcCtD
Ixabepilone—Immune system disorder—Docetaxel—skin cancer	5.63e-05	0.000907	CcSEcCtD
Ixabepilone—Mediastinal disorder—Docetaxel—skin cancer	5.62e-05	0.000905	CcSEcCtD
Ixabepilone—Chills—Docetaxel—skin cancer	5.6e-05	0.000901	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Fluorouracil—skin cancer	5.59e-05	0.000901	CcSEcCtD
Ixabepilone—Pruritus—Bleomycin—skin cancer	5.59e-05	0.0009	CcSEcCtD
Ixabepilone—Insomnia—Fluorouracil—skin cancer	5.55e-05	0.000894	CcSEcCtD
Ixabepilone—Paraesthesia—Fluorouracil—skin cancer	5.51e-05	0.000888	CcSEcCtD
Ixabepilone—Alopecia—Docetaxel—skin cancer	5.51e-05	0.000887	CcSEcCtD
Ixabepilone—Dyspnoea—Fluorouracil—skin cancer	5.47e-05	0.000881	CcSEcCtD
Ixabepilone—Mental disorder—Docetaxel—skin cancer	5.46e-05	0.00088	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Temozolomide—skin cancer	5.45e-05	0.000877	CcSEcCtD
Ixabepilone—Malnutrition—Docetaxel—skin cancer	5.43e-05	0.000874	CcSEcCtD
Ixabepilone—Hypersensitivity—Dactinomycin—skin cancer	5.43e-05	0.000874	CcSEcCtD
Ixabepilone—Decreased appetite—Fluorouracil—skin cancer	5.34e-05	0.000859	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Fluorouracil—skin cancer	5.3e-05	0.000853	CcSEcCtD
Ixabepilone—Asthenia—Dactinomycin—skin cancer	5.28e-05	0.000851	CcSEcCtD
Ixabepilone—Abdominal pain—Temozolomide—skin cancer	5.27e-05	0.000848	CcSEcCtD
Ixabepilone—Body temperature increased—Temozolomide—skin cancer	5.27e-05	0.000848	CcSEcCtD
Ixabepilone—Pain—Fluorouracil—skin cancer	5.25e-05	0.000845	CcSEcCtD
Ixabepilone—Muscle spasms—Docetaxel—skin cancer	5.22e-05	0.00084	CcSEcCtD
Ixabepilone—Diarrhoea—Dactinomycin—skin cancer	5.04e-05	0.000812	CcSEcCtD
Ixabepilone—Vomiting—Bleomycin—skin cancer	5.02e-05	0.000809	CcSEcCtD
Ixabepilone—Anaemia—Docetaxel—skin cancer	5.02e-05	0.000808	CcSEcCtD
Ixabepilone—Rash—Bleomycin—skin cancer	4.98e-05	0.000802	CcSEcCtD
Ixabepilone—Dermatitis—Bleomycin—skin cancer	4.97e-05	0.000801	CcSEcCtD
Ixabepilone—Hypersensitivity—Temozolomide—skin cancer	4.91e-05	0.00079	CcSEcCtD
Ixabepilone—Syncope—Docetaxel—skin cancer	4.87e-05	0.000784	CcSEcCtD
Ixabepilone—Leukopenia—Docetaxel—skin cancer	4.86e-05	0.000782	CcSEcCtD
Ixabepilone—Body temperature increased—Fluorouracil—skin cancer	4.85e-05	0.000781	CcSEcCtD
Ixabepilone—Asthenia—Temozolomide—skin cancer	4.78e-05	0.00077	CcSEcCtD
Ixabepilone—Loss of consciousness—Docetaxel—skin cancer	4.77e-05	0.000768	CcSEcCtD
Ixabepilone—Cough—Docetaxel—skin cancer	4.74e-05	0.000763	CcSEcCtD
Ixabepilone—Pruritus—Temozolomide—skin cancer	4.71e-05	0.000759	CcSEcCtD
Ixabepilone—Nausea—Bleomycin—skin cancer	4.69e-05	0.000755	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—skin cancer	4.68e-05	0.000754	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—skin cancer	4.64e-05	0.000748	CcSEcCtD
Ixabepilone—Myalgia—Docetaxel—skin cancer	4.62e-05	0.000744	CcSEcCtD
Ixabepilone—Chest pain—Docetaxel—skin cancer	4.62e-05	0.000744	CcSEcCtD
Ixabepilone—Arthralgia—Docetaxel—skin cancer	4.62e-05	0.000744	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	4.59e-05	0.000739	CcSEcCtD
Ixabepilone—Diarrhoea—Temozolomide—skin cancer	4.56e-05	0.000734	CcSEcCtD
Ixabepilone—Hypersensitivity—Fluorouracil—skin cancer	4.52e-05	0.000728	CcSEcCtD
Ixabepilone—Oedema—Docetaxel—skin cancer	4.43e-05	0.000713	CcSEcCtD
Ixabepilone—Dizziness—Temozolomide—skin cancer	4.41e-05	0.000709	CcSEcCtD
Ixabepilone—Infection—Docetaxel—skin cancer	4.4e-05	0.000709	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—skin cancer	4.37e-05	0.000705	CcSEcCtD
Ixabepilone—Shock—Docetaxel—skin cancer	4.36e-05	0.000702	CcSEcCtD
Ixabepilone—Nervous system disorder—Docetaxel—skin cancer	4.34e-05	0.0007	CcSEcCtD
Ixabepilone—Pruritus—Fluorouracil—skin cancer	4.34e-05	0.000699	CcSEcCtD
Ixabepilone—Thrombocytopenia—Docetaxel—skin cancer	4.34e-05	0.000698	CcSEcCtD
Ixabepilone—Skin disorder—Docetaxel—skin cancer	4.3e-05	0.000693	CcSEcCtD
Ixabepilone—Vomiting—Temozolomide—skin cancer	4.24e-05	0.000682	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—skin cancer	4.22e-05	0.00068	CcSEcCtD
Ixabepilone—Rash—Temozolomide—skin cancer	4.2e-05	0.000676	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—skin cancer	4.2e-05	0.000676	CcSEcCtD
Ixabepilone—Dermatitis—Temozolomide—skin cancer	4.2e-05	0.000676	CcSEcCtD
Ixabepilone—Headache—Temozolomide—skin cancer	4.17e-05	0.000672	CcSEcCtD
Ixabepilone—Hypotension—Docetaxel—skin cancer	4.14e-05	0.000667	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—skin cancer	4.06e-05	0.000654	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—skin cancer	4.04e-05	0.00065	CcSEcCtD
Ixabepilone—Insomnia—Docetaxel—skin cancer	4.01e-05	0.000645	CcSEcCtD
Ixabepilone—Paraesthesia—Docetaxel—skin cancer	3.98e-05	0.000641	CcSEcCtD
Ixabepilone—Nausea—Temozolomide—skin cancer	3.96e-05	0.000637	CcSEcCtD
Ixabepilone—Dyspnoea—Docetaxel—skin cancer	3.95e-05	0.000636	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—skin cancer	3.9e-05	0.000628	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—skin cancer	3.87e-05	0.000623	CcSEcCtD
Ixabepilone—Dermatitis—Fluorouracil—skin cancer	3.87e-05	0.000623	CcSEcCtD
Ixabepilone—Decreased appetite—Docetaxel—skin cancer	3.85e-05	0.00062	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—skin cancer	3.85e-05	0.000619	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—skin cancer	3.82e-05	0.000616	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—skin cancer	3.82e-05	0.000615	CcSEcCtD
Ixabepilone—Pain—Docetaxel—skin cancer	3.79e-05	0.00061	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—skin cancer	3.79e-05	0.00061	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—skin cancer	3.65e-05	0.000587	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Docetaxel—skin cancer	3.62e-05	0.000583	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—skin cancer	3.5e-05	0.000564	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—skin cancer	3.5e-05	0.000564	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—skin cancer	3.26e-05	0.000526	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—skin cancer	3.18e-05	0.000512	CcSEcCtD
Ixabepilone—Pruritus—Docetaxel—skin cancer	3.13e-05	0.000505	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—skin cancer	3.03e-05	0.000488	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—skin cancer	2.93e-05	0.000472	CcSEcCtD
Ixabepilone—Vomiting—Docetaxel—skin cancer	2.82e-05	0.000454	CcSEcCtD
Ixabepilone—Rash—Docetaxel—skin cancer	2.79e-05	0.00045	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—skin cancer	2.79e-05	0.000449	CcSEcCtD
Ixabepilone—Headache—Docetaxel—skin cancer	2.78e-05	0.000447	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—skin cancer	2.63e-05	0.000424	CcSEcCtD
